WKSWA
CRSP icon

White Knight Strategic Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,630
Closed -$250K 84
2024
Q2
$250K Buy
4,630
+75
+2% +$4.05K 0.25% 68
2024
Q1
$310K Buy
4,555
+115
+3% +$7.84K 0.32% 55
2023
Q4
$278K Buy
+4,440
New +$278K 0.32% 56